Product Images Sildenafil Citrate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Sildenafil Citrate NDC 51655-793 by Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 51655 793 20 Master Bottle Label Approval Rev A 01 22

Label - 51655 793 20 Master Bottle Label Approval   Rev A 01 22

This is a description of Sildenafil tablets, USP with 20mg strength. The package contains 20 tablets to be stored within a specific temperature range. The dosage and other important information should be checked from the instructional insert. It is repackaged from a specific lot number by TruPharma LLC and repackaged by Northwind Pharmaceuticals from Indianapolis. The tablets contain Sildenafil citrate USP, which is equivalent to 20mg. The expiration date and lot number are also specified.*

Graph - sildenafil tablets usp 20mg figure 06

Graph - sildenafil tablets usp 20mg figure 06

Graph - sildenafil tablets usp 20mg figure 07

Graph - sildenafil tablets usp 20mg figure 07

This is a table showing the recommended nodose adjustment for various drugs interaction with Sildenafil. The table includes details of drugs such as Acitomycin®, Bosentan, Cimetidines, Evomyeint, Maslox®, OralContraceptives™, Rionavit, and Sapionis K8. The table provides information on how to adjust the dosages of these drugs concerning the administration of Sildenafil.*

Graph - sildenafil tablets usp 20mg figure 08

Graph - sildenafil tablets usp 20mg figure 08

This is a drug interaction chart that shows how acenocoumarol interacts with other drugs. The chart displays the recommended fold change and 90% CI for INR AUC, INR Cmax, BT, AUC, and Cmax when acenocoumarol is taken together with other drugs. The drugs shown include aspirin, atorvastatin, bosentan, doxazosin, ethinyloestradiol, levonorgestrel, phenprocoumon, ritonavir, saquinavir, and tolbutamide. The interaction of ritonavir on sildenafil PK is also mentioned. Sildenafil added to bosentan therapy does not show any benefit on exercise capacity.*

Graph - sildenafil tablets usp 20mg figure 09

Graph - sildenafil tablets usp 20mg figure 09

This appears to be a graph showing changes in meters over time in a study. The study had a placebo group and three groups receiving different doses of sildenafil (20mg, 40mg, and 80mg) taken three times daily. The changes in meters are likely referring to some kind of physical measurement or activity being tracked. No further details about the study or what the measurement represents are provided.*

Graph - sildenafil tablets usp 20mg figure 10

Graph - sildenafil tablets usp 20mg figure 10

This appears to be a table containing data related to a study on the effects of Sildenafil on individuals with Idiopathic Pulmonary Arterial Hypertension. The table shows baseline walk distance, age, gender, and mean pulmonary artery pressure among other variables, with corresponding numerical values. Additionally, there is a graph displaying placebo-corrected change in 6-minute walk distance.*

Graph - sildenafil tablets usp 20mg figure 11

Graph - sildenafil tablets usp 20mg figure 11

Graph - sildenafil tablets usp 20mg figure 12

Graph - sildenafil tablets usp 20mg figure 12

Structure Formula - sildenafil tablets usp 20mg structure

Structure Formula - sildenafil tablets usp 20mg structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.